Novo Nordisk’s Ozempic named in latest Medicare price negotiations
The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.
Pricing and Market Access
JP Morgan 2025: Almirall updates strategy with focus on medical dermatology
Pharma to raise prices on more than 250 drugs in the US from January 2025
Setback for UK pharma as government sets unexpectedly high VPAG payback rate in 2025
Denmark’s HTA evolution
Navigating medicine pricing in Turkiye: the pharmaceutical Euro exchange rate
Exploring drug shortages in European markets: the causes, analysis, and response
Psoriasis biosimilars and pricing changes herald treatment paradigm disruptions
